Press Releases on January 13, 2020 - EIN Presswire - Press Release Distribution Service

Published on January 13, 2020 - 13:00 GMT

MRI Interventions, Inc. To Change Corporate Name to ClearPoint Neuro, Inc.

IRVINE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, today announced plans to change its corporate name to ClearPoint Neuro, Inc. As part of the name change, the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 13:00 GMT

Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners ...

CAMBRIDGE, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 13:00 GMT

Rubius Therapeutics Announces 2020 Objectives and Provides Operational Update at the 38th Annual J.P. Morgan Healthcare Conference

RTX-240 Investigational New Drug Application for Cancer on File with U.S. Food and Drug Administration Rubius Manufacturing Facility Operational Nine Months Ahead of Schedule and Ready to Supply Future Clinical Trials Focus on Clinical Development to …

Distribution channels:

Published on January 13, 2020 - 13:00 GMT

R1 Announces Agreement to Acquire SCI Solutions, a Leading Provider of Digital Patient Engagement Solutions

CHICAGO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced a definitive agreement to acquire SCI Solutions, Inc. (SCI), a leading …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 13, 2020 - 13:00 GMT

Tauriga Sciences, Inc. Changes Subsidiary Name to Tauriga Pharma Corp. to Reflect the Ongoing Development of Pharmaceutical Anti-...

NEW YORK, NY, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR

Published on January 13, 2020 - 13:00 GMT

IntelGenx Provides Commercial Update on its Two Lead VersaFilm® Product Candidates, Cannabis-Infused Oral Film and RIZAPORT®

SAINT LAURENT, Quebec, Jan. 13, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today provided a commercial update on its two lead product candidates, cannabis-infused VersaFilm® and …

Distribution channels:

Published on January 13, 2020 - 13:00 GMT

BrewBilt Merger Complete and $8M in Current and Projected Sales

KELSEYVILLE, CA, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Vet Online Supply, Inc. (OTC PINK:VTNL) (“Vet Online Supply” or the “Company”), BrewBilt Manufacturing is one of the only California companies that custom designs, handcrafts, and …

Distribution channels: IT Industry, Media, Advertising & PR

Published on January 13, 2020 - 13:00 GMT

CloudJumper Names Amie Ray to Post of Enterprise Channel Sales Manager

GARNER, N.C., Jan. 13, 2020 (GLOBE NEWSWIRE) -- CloudJumper today announces the appointment of Amie Ray as enterprise channel sales manager. As Enterprise Channel Sales Manager, Ray will open new alliances and distribution channels for the CloudJumper …

Distribution channels: Companies, IT Industry ...

Published on January 13, 2020 - 13:00 GMT

Tetra Bio-Pharma Receives Favorable Letter of Advice from USA FDA for QIXLEEF

FDA Feedback continues to support the development of QIXLEEF for second- or third-line therapy for adult patients with uncontrolled pain FDA advice consistent with previous feedback paving the way for the marketing approval of QIXLEEF OTTAWA, Jan. 13, 2020 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 13, 2020 - 13:00 GMT

ContraFect Partners with Leading Orthopedic Center in Europe to Provide Compassionate Use of Exebacase to Patients with Chronic ...

YONKERS, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 13:00 GMT

AzurRx BioPharma Announces Closing of $6.9 Million Private Placement

NEW YORK, Jan. 13, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced the closing of a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 13:00 GMT

REPEAT - Gold Lion Enters into Agreements to Acquire the Cuteye Group of Properties

VANCOUVER, British Columbia, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Gold Lion Resources Inc. (“Gold Lion” or the “Company”) (CSE: GL) (FWB: 2BC) is pleased to announce it has entered into an acquisition agreement and an amalgamation agreement (collectively, the …

Distribution channels: Companies, Media, Advertising & PR ...

Published on January 13, 2020 - 13:00 GMT

Extendicare Announces the Renewal of its Normal Course Issuer Bid

MARKHAM, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it has received the approval of the Toronto Stock Exchange (the “TSX”) to renew its normal course issuer bid (the “NCIB”) …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 13:00 GMT

Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) ...

NOVATO, Calif. and TOKYO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Kyowa Kirin Co., Ltd., (Kyowa Kirin, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 13:00 GMT

Fate Therapeutics Announces Expansion of FT516 Clinical Investigation and Publication of Preclinical Data in the Journal Blood

FT516 IND Application Cleared by FDA for Advanced Solid Tumors in Combination with PDL1-, EGFR- and HER2-targeting Therapeutic Antibodies Published Preclinical Data Demonstrate iPSC-derived NK Cells Engineered with High-affinity, Non-cleavable CD16 Enhance …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2020 - 13:00 GMT

MediWound Expands its Distribution Agreement with GENFA MEDICA SA to Market NexoBrid in Ukraine and the Baltic States

YAVNE, Israel, Jan. 13, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced the expansion of its …

Distribution channels:

Published on January 13, 2020 - 13:00 GMT

Pixelworks and OPPO Group Sign Multi-Year Collaboration Agreement

SAN JOSE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, today announced that OPPO Group has signed a multi-year collaboration agreement with the Company …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 13, 2020 - 13:00 GMT

Shaw Announces First Quarter Fiscal 2020 Results

Consolidated revenue increased 2.1% and adjusted EBITDA improved 8.1% year-over-year, in line with expectations and including the impact of IFRS 16 in fiscal 2020 Wireless service revenue increased 18.1% year-over-year as Freedom Mobile continues to grow …

Distribution channels: Media, Advertising & PR, Telecommunications ...

Published on January 13, 2020 - 13:00 GMT

PetIQ, Inc. Enters Into Definitive Agreement to Acquire the Capstar® portfolio of products from Elanco

EAGLE, Idaho, Jan. 13, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, and Elanco today announced they have executed a definitive agreement under which PetIQ will acquire …

Distribution channels: Companies, Consumer Goods ...

Published on January 13, 2020 - 13:00 GMT

Tabula Rasa HealthCare Retains 99.1% of PACE Clients to Start 2020

MOORESTOWN, N.J., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today a client retention rate of 99.1% in the PACE (Programs of All …

Distribution channels: Healthcare & Pharmaceuticals Industry ...